Mechanism of Action
- Shamila Habibi
- Jul 2
- 2 min read
Updated: 5 hours ago
Chemotherapy
Anthracyclines: 💉
Intercalate into DNA, inhibit topoisomerase II, generate free radicals → DNA damage → cell death
Doxorubicin (Adriamycin)
Daunorubicin
Epirubicin
Idarubicin (Idamycin)
Topoisomerase inhibitors: 💉
Interfere with DNA unwinding and replication → cell death
Topoisomerase I inhibitors:
Irinotecan
Topotecan
Topoisomerase II inhibitors:
Doxorubicin (Adriamycin) (Anthracycline and Tomoisomerase II inh)
Etoposide
Alkylating agents:
DNA cross-linking → inhibits replication → cell death
Cyclophosphamide 💊 💉
Ifosfamide 💉
Busulfan 💉
Melphalan 💊 💉
Carmustine 💉
Lomustine 💊
Temozolomide (Temodar) 💊
Procarbazine 💊
Dacarbazine 💉
Microtubule-targeting agents: 💉
Disrupt mitotic spindle formation → mitotic arrest → cell death
Taxanes:
Paclitaxel (Taxol)
Docetaxel
Cabazitaxel
Vinca alkaloids:
Vincristine (Oncovin)
Vinblastine
Platinum compounds: 💉
DNA cross-linking → inhibits replication → cell death
Cisplatin
Carboplatin
Oxaliplatin
Antimetabolites:
Hypomethylating agents (DNA hypomethylation→ reactivation of tumor suppressor gene):
Acacitidine -SubQ
Decitabine 💉
Decitabine/cedazuridine (Inqovi) 💊
Antifolates:
Methotrexate 💊 💉
Pemetrexed (Alimta) 💉
Raltitrexed 💉
Purine analogues:
6-mercaptopurine 💊
6-thioguanine 💊
Fludarabine 💉
Cladribine 💉
Pyrimidine analogues:
Cytarabine 💉
5-fluorouracil (5-FU) 💉
Gemcitabine (Gemzar) 💉
Capecitabine (Xeloda) 💊
Floxuridine 💉
Immunotherapy
PDL-1 inhibitors: 💉
Atezolizumab
Durvalumab (Imfinzi)
Avelumab
PD-1 inhibitors: 💉
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Tislelizumab
Cemiplimab
Dostarlimab
Retifanlimab
Toripalimab
CTLA-4 inhibitors: 💉
Ipilimumab
Tremelimumab
Bispecific T-cell engager (BiTE): 💉
Binds two targets simultaneously (CD3 on T cells and Tumor-associated antigen on cancer cells) → directs T cells to the tumor → T-cell mediated cytotoxicity
Blinatumomab
Teclistamab
Immunomodulatory imide drugs (IMiDs): 💊
Lenalidomide
Thalidomide
Pomalidomide
Targeted Therapy
BRAF inhibitors: 💊
Vemurafenib
Dabrafenib
Encorafenib
Sorafenib
MEK inhibitors: 💊
(Often combined with BRAF inhibitors)
Trametinib
Cobimetinib
mTOR inhibitors:
Sirolimus 💊
Everolimus 💊
Temsirolimus 💉
VEGF inhibitors: 💉
Block VEGF signaling → inhibit tumor angiogenesis → reduce tumor growth
Bevacizumab (Avastin)
Ramucirumab
Aflibercept
Small molecule VEGFR (multi-kinase) inhibitors: 💊
Sunitinib
Sorafenib (VEGFR and BRAF inhibitor)
Pazopanib
Axitinib
Cabozantinib
Lenvatinib
KRAS inhibitors: 💊
Sotorasib
Adagrasib
BCR-ABL inhibitors: 💊
Imatinib
Dasatinib
Nilotinib
Ponatinib
EGFR inhibitors: 💊
Erlotinib
Gefitinib
Osimertinib (Tagrisso)
NTRK inhibitors: 💊
Larotrectinib
Entrectinib
Repotrectinib
BTK inhibitors: 💊
Ibrutinib
Zanubrutinib
Pirtobrutinib
Remibrutinib
ROS1 inhibitors: 💊
Entrectinib (NTRK and ROS1 inh)
Repotrectinib (NTRK and ROS1 inh)
Crizotinib (ALK and ROS1 inh)
Lorlatinib (ALK and ROS1 inh)
ALK inhibitors: 💊
Crizotinib
Lorlatinib
Alectinib
Brigatinib
RET inhibitors: 💊
Selpercatinib
Pralsetinib
HER-2 inhibitors:
Tyrosine kinase inhibitor: 💊
Lapatinib
Neratinib
Monoclonal antibody: 💉
Trastuzumab (Herceptin)
Pertuzumab (Perjeta)
Margetuximab
Antibody-drug conjugates: 💉
Ado-trastuzumab emtansine
Trastuzumab deruxtecan (Enhertu)
Proteasome inhibitors:
Bortezomib (Velcade) 💉
Carfilzomib 💉
Ixazomib 💊
Phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitors: 💊
Idelalisib
Umbralisib
Zandelisib
Linperlisib
Leniolisib
CD20 inhibitors: 💉
Rituximab
Ublituximab
Obinutuzumab
Ofatumumab
Ocrelizumab